These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32097993)

  • 41. Noninvasive prenatal testing for fetal aneuploidy and single gene disorders.
    Skrzypek H; Hui L
    Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():26-38. PubMed ID: 28342726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-invasive prenatal genetic testing: a study of public attitudes.
    Kelly SE; Farrimond HR
    Public Health Genomics; 2012; 15(2):73-81. PubMed ID: 22094262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing.
    Liang D; Lv W; Wang H; Xu L; Liu J; Li H; Hu L; Peng Y; Wu L
    Prenat Diagn; 2013 May; 33(5):409-15. PubMed ID: 23299662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada.
    Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS
    Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A one-step real-time PCR assay for rapid prenatal diagnosis of sickle cell disease and detection of maternal contamination.
    Costa C; Pissard S; Girodon E; Huot D; Goossens M
    Mol Diagn; 2003; 7(1):45-8. PubMed ID: 14529320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results from a reference laboratory for prenatal diagnosis of sickle cell disorders in Cuba.
    Granda H; Gispert S; Martinez G; Gomez M; Ferreira R; Collazo T; Magariño C; Heredero L
    Prenat Diagn; 1994 Aug; 14(8):659-62. PubMed ID: 7991507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance of the neoBona test: a new paired-end massively parallel shotgun sequencing approach for cell-free DNA-based aneuploidy screening.
    Cirigliano V; Ordoñez E; Rueda L; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):460-464. PubMed ID: 27981672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting.
    Rahimy MC; Gangbo A; Adjou R; Deguenon C; Goussanou S; Alihonou E
    Blood; 2000 Sep; 96(5):1685-9. PubMed ID: 10961864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-invasive prenatal diagnosis (NIPD) of cystic fibrosis: an optimized protocol using MEMO fluorescent PCR to detect the p.Phe508del mutation.
    Guissart C; Dubucs C; Raynal C; Girardet A; Tran Mau Them F; Debant V; Rouzier C; Boureau-Wirth A; Haquet E; Puechberty J; Bieth E; Dupin Deguine D; Khau Van Kien P; Brechard MP; Pritchard V; Koenig M; Claustres M; Vincent MC
    J Cyst Fibros; 2017 Mar; 16(2):198-206. PubMed ID: 28040480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-invasive prenatal diagnosis of single gene disorders with enhanced relative haplotype dosage analysis for diagnostic implementation.
    Pacault M; Verebi C; Champion M; Orhant L; Perrier A; Girodon E; Leturcq F; Vidaud D; Férec C; Bienvenu T; Daveau R; Nectoux J
    PLoS One; 2023; 18(4):e0280976. PubMed ID: 37093806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Legler TJ
    Prenat Diagn; 2011 Dec; 31(13):1300-4. PubMed ID: 22030893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iron deficiency anaemia in Jamaican children, aged 1-5 years, with sickle cell disease.
    King L; Reid M; Forrester TE
    West Indian Med J; 2005 Oct; 54(5):292-6. PubMed ID: 16459510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Density-based separation in multiphase systems provides a simple method to identify sickle cell disease.
    Kumar AA; Patton MR; Hennek JW; Lee SY; D'Alesio-Spina G; Yang X; Kanter J; Shevkoplyas SS; Brugnara C; Whitesides GM
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14864-9. PubMed ID: 25197072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cuban programme for prevention of sickle cell disease.
    Granda H; Gispert S; Dorticós A; Martín M; Cuadras Y; Calvo M; Martínez G; Zayas MA; Oliva JA; Heredero L
    Lancet; 1991 Jan; 337(8734):152-3. PubMed ID: 1670797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies.
    Freeman K; Szczepura A; Osipenko L
    Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):91-8. PubMed ID: 19081172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users' perspective.
    Lewis C; Hill M; Skirton H; Chitty LS
    Eur J Hum Genet; 2012 Nov; 20(11):1127-33. PubMed ID: 22453293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sickle cell disease and increased adverse maternal and perinatal outcomes in different genotypes.
    Figueira CO; Guida JPS; Surita FG; Antolini-Tavares A; Saad ST; Costa FF; Fertrin KY; Costa ML
    Hematol Transfus Cell Ther; 2024 Mar; ():. PubMed ID: 38494406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.